Sign in
Bruce Broussard
Photo: The White House from Washington, DC, Public domain, via Wikimedia Commons33

Bruce Broussard

American business executive

Bruce Dale Broussard (born 1961 or 1962) is an American business executive. From 2013 to 2024, Broussard was chief executive officer (CEO) of Humana, a healthcare company with headquarters in Louisville, Kentucky.2

From Wikipedia’s article on Bruce Broussard (this version), CC BY-SA 4.0.

Born 1963.1

About

Prior to joining Humana, he had several executive roles, including CEO of McKesson Specialty/US Oncology.

Broussard has participated in business advocacy organizations such as the Business Roundtable, The Business Council, and the American Heart Association CEO Roundtable. He is currently Interim CEO of HP Inc., and a member and previous chair of America's Health Insurance Plans. Broussard was chair of the Trust for the National Mall, a nonprofit philanthropic partner of the National Park Service dedicated to restoring and preserving the National Mall.

From Wikipedia’s article on Bruce Broussard, shared under CC BY-SA 4.0.2

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Aug 15, 2026Granted 192 shares at $188.44 of Marsh & McLennan Companies23
  • Jul 1, 2026Granted 3,800 shares of Takeda Pharmaceutical Company25
  • Jun 1, 2026Granted 1,349 shares at $159.28 of Marsh & McLennan Companies26
  • Apr 14, 2025Granted 4,784 shares at $24.04 of HP Inc.21
  • Apr 14, 2025Granted 9,568 shares of HP Inc.21
  • Apr 22, 2024Granted 3,791 shares at $27.70 of HP Inc.27
  • Apr 22, 2024Granted 7,943 shares of HP Inc.27
  • Feb 22, 2024Shares withheld for tax 8,473 shares at $366.11 of Humana28
  • Feb 22, 2024Exercised options 22,572 shares of Humana28
  • Feb 21, 2024Granted 21,786 shares of Humana28
  • Dec 15, 2023Shares withheld for tax 900 shares at $463.58 of Humana29
  • Dec 15, 2023Exercised options 2,286 shares of Humana29
  • Dec 15, 2023Shares withheld for tax 860 shares at $463.58 of Humana29
  • Dec 15, 2023Exercised options 2,184 shares of Humana29
  • Dec 15, 2023Shares withheld for tax 970 shares at $463.58 of Humana29
  • Dec 15, 2023Exercised options 2,465 shares of Humana29
  • Apr 24, 2023Granted 3,563 shares at $29.47 of HP Inc.30
  • Apr 24, 2023Granted 7,466 shares of HP Inc.30
  • Feb 27, 2023Sold 17,575 shares at $505.85 of Humana31
  • Feb 24, 2023Shares withheld for tax 10,919 shares at $510.24 of Humana31
  • Feb 24, 2023Exercised options 28,494 shares of Humana31
  • Dec 15, 2022Shares withheld for tax 860 shares at $510.02 of Humana32
  • Dec 15, 2022Exercised options 2,183 shares of Humana32
  • Dec 15, 2022Shares withheld for tax 970 shares at $510.02 of Humana32
  • Dec 15, 2022Exercised options 2,464 shares of Humana32

Trade performance

DateStockTradeValueReturn sinceVs S&P sinceVs S&P, 1 year
Feb 27, 2023HUMSale$8.9M−14.7%+108.7%+55.8%
Dec 12, 2022HUMSale$3.7M−18.5%+111.9%+25.4%
Nov 3, 2022HUMSale$5.1M−23.2%+131.3%+32.4%
Mar 31, 2022HPQBuy$249.7K−15.0%−85.9%−9.8%
Nov 5, 2021HUMSale$22.7M−4.7%+69.4%−41.3%
Feb 23, 2021HUMSale$10.4M+14.3%+84.9%−0.5%
Nov 4, 2020HUMSale$29.1M−4.4%+129.0%+35.6%
Feb 22, 2019HUMSale$7.6M+39.6%+136.9%+3.7%

Returns are price-only (no dividends), measured from the trade date.

Career

Occupation: businessperson.7

Beginning in 1990 he was vice president and treasurer for Continental Medical Systems. Three years later he became chief financial officer at Sun Healthcare Group. During the next year he was chief financial officer and executive vice president at Regency Health Services. From 1997 to 2000 he was CEO of Harbor Dental.

In 2000 Broussard began working for US Oncology, which was acquired by the McKesson Corporation in 2010. For six years, he was the company's chief financial officer. He became president in 2005 and was head of investor relations. He was also in charge of pharmaceutical services, pharmaceutical distribution, marketing, and growth initiatives. He became CEO of US Oncology in 2008, and chairman a year later.

In 2011, Broussard became president of Humana and in 2013, was promoted to CEO, succeeding Michael B. McCallister. Under Broussard's tenure, Humana's revenue grew to $92.9 billion in 2022 from $39.1 billion in 2012 and its net income doubled to $2.8 billion. Its stock price increased from $63 to over $500.

Since 2013, Broussard's focus on Humana's Medicare Advantage business saw a 17 percent increase in membership compared to traditional Medicare, outpacing the rest of the industry. He has also been credited with expanding Humana's focus from solely health insurance to an integrated healthcare model.

In 2023, Humana announced that Broussard would step down in 2024, to be replaced by Envision Healthcare president and CEO Jim Rechtin, after which Broussard will continue in a strategic advisor role into 2025.

Broussard's board roles include HP Inc., and chair of the Trust for the National Mall. He joined the board of Marsh McLennan in July 2025.

In February 2026, Broussard was announced as Interim CEO of HP Inc.. He was appointed after previous CEO Enrique Lores stepped down.

From Wikipedia’s article on Bruce Broussard (this version), CC BY-SA 4.0.

Personal life

  • CitizenshipUnited States8

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
    Wikidata and SEC EDGARHP Inc., Board member
  15. 15
    Wikidata and SEC EDGARHumana, Board member
  16. 16
    Wikidata and SEC EDGARHumana, Chief executive officer
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33